Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982

T. J. Liesegang, L. J. Melton 3rd, P. J. Daly and D. M. Ilstrup
Department of Ophthalmology, Mayo Clinic and Foundation, Rochester, Minn.

Over the period 1950 through 1982, 122 Rochester, Minn residents had their first episode of ocular herpes simplex virus infection, for an age- and sex-adjusted incidence of 8.4 new cases per 100,000 person-years (95% confidence intervals [CI], 6.9 to 9.9 cases). These initial episodes involved lid or conjunctiva in 54%, superficial cornea in 63%, deeper cornea in 6%, and uveitis in 4%. An additional 29 residents had episodes of ocular herpes other than their first. Altogether, these 151 residents had 294 episodes of ocular herpes simplex infection, for an adjusted incidence of 20.7 episodes per 100,000 person-years (95% CI, 18.3 to 23.1 episodes). Age-adjusted rates by sex were comparable. There were no seasonal trends in incidence, but rates increased with time. On January 1, 1980, the prevalence of a history of ocular herpes simplex infection was 149 per 100,000 population (95% CI, 115 to 183).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role for 3-o-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts.
Tiwari et al.
J. Virol. 2006;80:8970-8980.
ABSTRACT | FULL TEXT  

Conjunctival dendrite in a case of primary herpes simplex infection
Sridhar et al.
Br. J. Ophthalmol. 2004;88:590-591.
FULL TEXT  

The bovine herpesvirus-1 LR ORF2 is critical for this gene's ability to restore the high wild-type reactivation phenotype to a herpes simplex virus-1 LAT null mutant
Mott et al.
J. Gen. Virol. 2003;84:2975-2985.
ABSTRACT | FULL TEXT  

HSV1 Latency Sites after Inoculation in the Lip: Assessment of their Localization and Connections to the Eye
Labetoulle et al.
IOVS 2003;44:217-225.
ABSTRACT | FULL TEXT  

Prevention of Herpes Simplex Virus Eye Disease: A Cost-effectiveness Analysis
Lairson et al.
Arch Ophthalmol 2003;121:108-112.
ABSTRACT | FULL TEXT  

Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo
Lubinski et al.
J. Virol. 2002;76:9232-9241.
ABSTRACT | FULL TEXT  

The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin
Halberstadt et al.
Br. J. Ophthalmol. 2002;86:646-652.
ABSTRACT | FULL TEXT  

Herpes Simplex Virus Type 1 Entry Is Inhibited by the Cobalt Chelate Complex CTC-96
Schwartz et al.
J. Virol. 2001;75:4117-4128.
ABSTRACT | FULL TEXT  

Psychological Stress and Other Potential Triggers for Recurrences of Herpes Simplex Virus Eye Infections
Herpetic Eye Disease Study Group
Arch Ophthalmol 2000;118:1617-1625.
ABSTRACT | FULL TEXT  

The Spread of Herpes Simplex Virus Type 1 from Trigeminal Neurons to the Murine Cornea: an Immunoelectron Microscopy Study
Ohara et al.
J. Virol. 2000;74:4776-4786.
ABSTRACT | FULL TEXT  

Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?
ELNIFRO et al.
Br. J. Ophthalmol. 1999;83:622-627.
FULL TEXT  

Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis
Tambasco et al.
Arch Ophthalmol 1999;117:445-449.
ABSTRACT | FULL TEXT  

Oral Acyclovir Suppresses Recurrent Epithelial and Stromal Herpes Simplex
Langston
Arch Ophthalmol 1999;117:391-392.
FULL TEXT  

Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease
Wilhelmus et al.
NEJM 1998;339:300-306.
ABSTRACT | FULL TEXT  

Acyclovir for Recurrent Herpes Simplex Virus Ocular Disease
Jabs
NEJM 1998;339:340-341.
FULL TEXT